Does Cytomegalovirus Serology Impact Outcome After Pediatric Heart Transplantation?

CMV+ serology at time of pediatric heart transplantation had no demonstrable association with death or development of CAV. CMV− recipients who receive a CMV+ organ are at increased risk of clinical CMV disease. CMV prophylaxis was commonly used, although further studies are needed to establish an optimal approach for prevention of CMV disease in this population.